Covaxin production to get boost as govt approves manufacturing facility in Gujarat's Ankleshwar
India TV NewsUnion Health Minister Mansukh Mandaviya on Tuesday informed that the government has approved a vaccine manufacturing facility for the production of Bharat Biotech's Covaxin in Gujarat's Ankleshwar. From January 16 to August 5, 44.42 crore doses of Covishield were supplied by Serum Institute of India and 6.82 crore doses of Covaxin by Bharat Biotech for the National COVID-19 Vaccination Programme. Under the mission, facility augmentation of Bharat Biotech and one state public sector enterprise and two central public sector enterprises -- Haffkine Biopharmaceutical Corporation Ltd, Mumbai; Indian Immunologicals Limited, Hyderabad and Bharat Immunologicals Biologicals Limited, Bulandshahr -- for production of Covaxin have been supported. In addition, technology transfer of Covaxin production to Gujarat COVID Vaccine Consortium, including Hester Biosciences and OmniBRx Biotechnologies Pvt Ltd, led by Gujarat Biotechnology Research Centre, Department of Science and Technology, has also been facilitated.